{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T05:13:49Z","timestamp":1754111629350},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1984,10,1]],"date-time":"1984-10-01T00:00:00Z","timestamp":465436800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother. Pharmacol."],"published-print":{"date-parts":[[1984,10]]},"DOI":"10.1007\/bf00269029","type":"journal-article","created":{"date-parts":[[2004,9,29]],"date-time":"2004-09-29T04:25:46Z","timestamp":1096431946000},"page":"200-205","source":"Crossref","is-referenced-by-count":5,"title":["CNS toxicity and CSF pharmacokinetics of intraventricular DFMO and MGBG in beagle dogs"],"prefix":"10.1007","volume":"13","author":[{"given":"Victor A.","family":"Levin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Byrd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard L.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janice K.","family":"Borcich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"22","volume":"2","author":"MD Abeloff","year":"1983","unstructured":"Abeloff MD, Slavik M, Luk GD, Griffin CA, Hermann J, Blanc O, Sjoerdsma A, Baylin SB (1983) Phase I clinical and pharmacokinetic studies of ?-difluoromethylornithine (DFMO). Proc Soc Clin Oncol 2:22","journal-title":"Proc Soc Clin Oncol"},{"key":"CR2","first-page":"5158","volume":"41","author":"J Bartholeyns","year":"1981","unstructured":"Bartholeyns J, Koch-Weser J (1981) Effects of ?-difluoromethylornithine alone and in combination with adriamycin or vindesine on L1210 leukemia in mice, EMT6 solid tumors in mice, and solid tujors induced by injection of hepatoma tissue culture cells in rats. Cancer Res 41:5158","journal-title":"Cancer Res"},{"key":"CR3","first-page":"80","volume-title":"Biopharmaceutics and clinical pharmacokineties","author":"M Gibaldi","year":"1977","unstructured":"Gibaldi M (1977) Biopharmaceutics and clinical pharmacokineties. Lea & Febiger, Philadelphia, p 80"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0378-4347(00)80114-0","volume":"223","author":"J Grove","year":"1981","unstructured":"Grove J, Fozard JR, Mamont PS (1981) Assay of alpha-difluoromethylornithine in body fluids and tissues by automatic amino acid analysis. J Chromatogr 223:409","journal-title":"J Chromatogr"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/clpt.1981.150","volume":"2","author":"K Haegele","year":"1981","unstructured":"Haegele K, Alken R, Grove J, Schechter PJ, Koch-Weser J (1981) Kinetics of alpha-difluoromethylornithine: An irreversible inhibitor of ornithine decarboxylase. Clin Pharmacol Ther 2:210","journal-title":"Clin Pharmacol Ther"},{"key":"CR6","first-page":"2783","volume":"41","author":"DT Hung","year":"1981","unstructured":"Hung DT, Deen DF, Seidenfield J, Marton LJ (1981) Sensitization of 9L rat brain gliosarcoma cells to 1,3-bis(2-chloroethyl)-1-nitrosourea by alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor. Cancer Res 41:2783","journal-title":"Cancer Res"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/BF00255762","volume":"10","author":"VA Levin","year":"1983","unstructured":"Levin VA, Csejtey J, Byrd DJ (1983) Brain, CSF, and tumor pharmacokinetics of ?-difluoromethylornithine in rats and dogs. Cancer Chemother Pharmacol 10:196","journal-title":"Cancer Chemother Pharmacol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1073\/pnas.78.4.2355","volume":"78","author":"GD Luk","year":"1981","unstructured":"Luk GD, Goodwin G, Marton LJ, Baylin SB (1981) Polyamines are necessary for the survival of human small-cell lung carcinoma in culture. Proc Natl Acad Sci USA 78:2355","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR9","first-page":"43","volume-title":"Enzyme-activated irreversible inhibitors","author":"PS Mamont","year":"1978","unstructured":"Mamont PS, Duchesne MC, Joder-Ohlenbusch AM, Grove J (1978) Effects of ornithine decarboxylase inhibitors on cultured cells. In: Seiler N, Jung MJ, Koch-Weser J (eds) Enzyme-activated irreversible inhibitors. Elsevier-North Holland, Amsterdam, p 43"},{"key":"CR10","unstructured":"Marton LJ (1984) Polyamines and cancer therapy. Ann Int Med (in press)"},{"key":"CR11","first-page":"4426","volume":"41","author":"LJ Marton","year":"1981","unstructured":"Marton LJ, Levin VA, Hervatin S, Koch-Weser J, McCann P, Sjoerdsma A (1981) Potentiation of the antitumor therapeutic effect of 1,3-bis(2-chloroethyl)-1-nitrosourea by ?-difluoromethylornithine, an ornithine decarboxylase inhibitor. Cancer Res 41:4426","journal-title":"Cancer Res"},{"key":"CR12","first-page":"33","volume-title":"Advances in polyamine research","author":"LJ Marton","year":"1983","unstructured":"Marton LJ, Oredsson SM, Hung DT, Deen DF (1983) Effects of polyamine depletion on the cytoxicity of cancer chemotherapeutic agents. In: Bachrach U, Kaye A, Chayen R (eds) Advances in polyamine research. Raven Press, New York, p 33"},{"key":"CR13","first-page":"3059","volume":"38","author":"NJ Prakash","year":"1978","unstructured":"Prakash NJ, Schechter PJ, Grove J, Koch-Weser J (1978) Effect of ?-difluoromethylornithine an enzyme-activated irreversible inhibitor of ornithine decarboxylase on L1210 leukemia in mice. Cancer Res 38:3059","journal-title":"Cancer Res"},{"key":"CR14","first-page":"459","volume":"41","author":"MG Rosenblum","year":"1981","unstructured":"Rosenblum MG, Stewart DJ, Yap BS, Leavens M, Benjamon RS, Loo TL (1981) Penetration of methylglyoxal bis(guanylhydrazone) into intracerebral tumors in humans. Cancer Res 41:459","journal-title":"Cancer Res"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/ijc.2910260508","volume":"26","author":"P Seppanen","year":"1980","unstructured":"Seppanen P, Alhonen-Hongisto L, Siimes M, Janne J (1980) Quantitation of methylglyoxal bis(guanylhydrazone) in blood plasma and leukemia cells of patients receiving the drug. Int J Cancer 26:571","journal-title":"Int J Cancer"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1200\/JCO.1983.1.1.52","volume":"1","author":"RP Warrell","year":"1983","unstructured":"Warrell RP, Burchenal JH (1983) Methylglyoxal-bis-(guanylhydrazone) (methyl-GAG): Current status and future prospects. J Clin Oncol 1:52","journal-title":"J Clin Oncol"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00269029.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00269029\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00269029","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T15:21:28Z","timestamp":1554304888000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00269029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1984,10]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1984,10]]}},"alternative-id":["BF00269029"],"URL":"https:\/\/doi.org\/10.1007\/bf00269029","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[1984,10]]}}}